Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
CN Stock MarketDetailed Quotes
301156 Shanghai Menon Animal Nutrition Technology
- 23.80
- +3.97+20.02%
Market Closed May 15 15:00 CST
3.35BMarket Cap68.59P/E (TTM)
23.80High19.61Low189.84KlotVolume19.88Open19.83Pre Close412.06MTurnover29.49%Turnover Ratio67.61P/E (Static)140.78MShares32.2152wk High4.55P/B1.53BFloat Cap10.6952wk Low23.80Limit Up64.38MShs Float32.21Historical High15.86Limit Down21.13%Amplitude6.86Historical Low0.42Dividend TTM21.71Avg Price71.94KlotAsk1.78%Div YieldTTM100Lot Size104.04KlotBid
Shanghai Menon Animal Nutrition Technology Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 1.99%99.85M | -2.87%489.93M | -9.19%340.19M | -6.53%207.71M | 7.57%97.91M | 4.37%504.42M | 18.33%374.64M | 12.70%222.21M | -14.24%91.02M | -11.52%483.32M |
| Operating revenue | 1.99%99.85M | -2.87%489.93M | -9.19%340.19M | -6.53%207.71M | 7.57%97.91M | 4.37%504.42M | 18.33%374.64M | 12.70%222.21M | -14.24%91.02M | -11.52%483.32M |
| Other operating revenue | ---- | -91.64%541.21K | ---- | -77.90%350.68K | ---- | -50.95%6.47M | ---- | -87.77%1.59M | ---- | 144.22%13.19M |
| Interest income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Commission income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Premiums earned | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Total operating cost | 4.34%91.83M | -2.06%437.28M | -6.43%307.31M | -4.82%188.07M | 6.05%88.01M | 5.66%446.46M | 19.74%328.43M | 17.27%197.61M | -6.58%82.99M | -11.19%422.54M |
| Operating cost | 2.42%71.74M | -1.33%348.75M | -7.13%242.93M | -5.39%149.36M | 6.54%70.04M | 3.05%353.44M | 15.60%261.58M | 10.01%157.88M | -12.37%65.74M | -10.84%342.99M |
| Operating tax surcharges | 81.81%1.01M | -0.56%2.78M | 2.64%1.98M | 4.94%1.31M | 66.64%555.36K | 32.20%2.8M | 47.08%1.93M | 33.51%1.25M | -24.54%333.28K | 4.65%2.11M |
| Operating expense | -1.88%7.85M | 1.82%38.3M | -7.64%26.94M | -2.50%17.4M | 8.74%8M | 21.72%37.61M | 41.43%29.17M | 72.63%17.85M | 55.20%7.35M | -13.77%30.9M |
| Administration expense | 14.44%7.55M | -10.79%31.62M | -1.95%23.25M | -3.45%14.61M | 5.01%6.6M | 13.57%35.45M | 27.26%23.71M | 65.70%15.13M | 34.70%6.29M | 10.90%31.21M |
| Financial expense | 34.00%-862.16K | -5.28%-5.05M | 43.10%-2.29M | 6.04%-2.97M | -256.22%-1.31M | 20.75%-4.8M | 34.34%-4.02M | -36.54%-3.16M | -158.75%-366.71K | -340.48%-6.05M |
| -Interest expense (Financial expense) | -80.27%2.47K | 76.51%-37.46K | 75.56%-42.51K | 73.77%-49.68K | -68.26%12.52K | -122.97%-159.46K | -121.38%-173.96K | -128.29%-189.41K | -87.58%39.43K | -37.97%694.2K |
| -Interest Income (Financial expense) | 60.40%-436.25K | 25.18%-2.91M | 21.27%-2.43M | 14.80%-1.85M | 5.75%-1.1M | -49.18%-3.89M | -81.33%-3.08M | -605.01%-2.17M | -1,221.23%-1.17M | -830.40%-2.61M |
| Research and development | 10.27%4.55M | -4.93%20.88M | -9.68%14.51M | -3.48%8.36M | 13.06%4.12M | 2.74%21.97M | 18.47%16.06M | 25.45%8.66M | 8.79%3.65M | -5.12%21.38M |
| Credit Impairment Loss | 191.54%1.68M | -149.02%-1.39M | -148.84%-668.62K | -97.73%42.67K | -73.90%574.98K | 205.84%2.83M | 977.65%1.37M | 375.28%1.88M | 486.64%2.2M | -674.58%-2.68M |
| Asset Impairment Loss | -79.35%-611.31K | -54.24%-1.36M | -347.17%-982.81K | 47.42%-262.96K | -10.37%-340.85K | -7.53%-882.64K | 73.69%-219.78K | 28.61%-500.13K | 37.85%-308.83K | 0.06%-820.84K |
| Other net revenue | 55.32%1.63M | -78.59%1.87M | -68.92%1.86M | -47.24%1.77M | -62.13%1.05M | 488.99%8.75M | 430.60%5.97M | 254.09%3.35M | 372.60%2.77M | -125.85%-2.25M |
| Fair value change income | -113.23%-70.9K | 9,687.78%1.32M | 2,461.10%727.22K | 367.56%368.17K | 1,495.41%535.84K | 95.19%-13.74K | 104.59%28.39K | 59.15%-137.6K | -35.43%-38.4K | -172.70%-285.53K |
| Invest income | 179.43%289.67K | -90.65%384.47K | -77.26%687.2K | -90.36%179.58K | -144.97%-364.69K | 1,053.98%4.11M | 282.26%3.02M | 199.09%1.86M | 2,080.98%810.95K | -115.12%-431.21K |
| Net open hedge income | --0 | ---- | --0 | --0 | --0 | ---- | --0 | --0 | --0 | --0 |
| -Including: Investment income associates | 104.34%22.74K | -133.24%-832.72K | -117.45%-305.83K | -146.56%-492.38K | -196.72%-523.57K | 249.74%2.51M | 178.49%1.75M | 150.56%1.06M | 568.60%541.35K | -181.59%-1.67M |
| Exchange income | --0 | ---- | --0 | --0 | --0 | ---- | --0 | --0 | --0 | --0 |
| Asset deal income | --2.19K | 911.30%353.74K | 3,202.63%353.25K | 383.44%20.08K | --0 | 288.63%34.98K | --10.7K | --4.15K | --0 | -1,469.30%-18.54K |
| Other revenue | -46.94%340.65K | -3.56%2.57M | -1.23%1.74M | 495.21%1.42M | 550.10%642K | 34.16%2.66M | 20.55%1.76M | -83.29%238.5K | -18.72%98.75K | -65.86%1.99M |
| Operating profit | -11.81%9.65M | -18.27%54.52M | -33.43%34.74M | -23.46%21.4M | 1.42%10.94M | 13.97%66.71M | 28.80%52.18M | 5.50%27.96M | -33.67%10.79M | -26.10%58.53M |
| Add:Non operating Income | --166.14K | -61.30%1.5M | -61.30%1.5M | 25,200.74%1.5M | --0 | 7,378.48%3.88M | 18,074.85%3.88M | -72.34%5.93K | -65.25%5.93K | -93.72%51.83K |
| Less:Non operating expense | -8.04%20.37K | -39.31%220K | -69.16%56.56K | -65.42%52.16K | 1,306.08%22.15K | 22.43%362.5K | 121.82%183.41K | 138.79%150.83K | -97.51%1.58K | -41.14%296.08K |
| Total profit | -10.30%9.8M | -20.54%55.8M | -35.24%36.18M | -17.86%22.85M | 1.18%10.92M | 20.48%70.22M | 38.12%55.87M | 5.12%27.81M | -33.46%10.79M | -26.71%58.28M |
| Less:Income tax cost | -31.74%912.44K | -13.36%6.22M | -25.05%4.57M | 4.93%2.85M | 6.55%1.34M | 23.86%7.17M | 57.90%6.1M | 0.87%2.72M | -14.08%1.25M | -35.41%5.79M |
| Net profit | -7.31%8.88M | -21.35%49.58M | -36.49%31.61M | -20.33%19.99M | 0.47%9.58M | 20.10%63.05M | 36.03%49.78M | 5.60%25.09M | -35.38%9.54M | -25.60%52.49M |
| Net profit from continuing operation | -7.31%8.88M | -21.35%49.58M | -36.49%31.61M | -20.33%19.99M | 0.47%9.58M | 20.10%63.05M | 36.03%49.78M | 5.60%25.09M | --9.54M | -25.60%52.49M |
| Net income from discontinuing operating | ---- | ---- | --0 | ---- | --0 | ---- | --0 | --0 | --0 | ---- |
| Less:Minority Profit | ---- | ---- | --0 | ---- | --0 | ---- | --0 | --0 | --0 | ---- |
| Net profit of parent company owners | -7.31%8.88M | -21.35%49.58M | -36.49%31.61M | -20.33%19.99M | 0.47%9.58M | 20.10%63.05M | 36.03%49.78M | 5.60%25.09M | -35.38%9.54M | -25.60%52.49M |
| Earning per share | ||||||||||
| Basic earning per share | -4.85%0.0628 | -20.70%0.3443 | -36.11%0.219 | -20.02%0.1382 | -22.54%0.066 | -18.93%0.4342 | -12.57%0.3428 | -38.92%0.1728 | -65.92%0.0852 | -54.61%0.5356 |
| Diluted earning per share | -4.85%0.0628 | -20.70%0.3443 | -36.11%0.219 | -20.02%0.1382 | -22.54%0.066 | -18.93%0.4342 | -12.57%0.3428 | -38.92%0.1728 | -65.92%0.0852 | -54.61%0.5356 |
| Other composite income | 0 | 0 | 0 | 0 | 0 | |||||
| Other composite income of parent company owners | ---- | ---- | --0 | ---- | --0 | ---- | --0 | --0 | --0 | ---- |
| Other composite income of minority owners | ---- | ---- | --0 | ---- | --0 | ---- | --0 | --0 | --0 | ---- |
| Total composite income | -7.31%8.88M | -21.35%49.58M | -36.49%31.61M | -20.33%19.99M | 0.47%9.58M | 20.10%63.05M | 36.03%49.78M | 5.60%25.09M | -35.38%9.54M | -25.60%52.49M |
| Total composite income of parent company owners | -7.31%8.88M | -21.35%49.58M | -36.49%31.61M | -20.33%19.99M | 0.47%9.58M | 20.10%63.05M | 36.03%49.78M | 5.60%25.09M | -35.38%9.54M | -25.60%52.49M |
| Total composite income of minority owners | ---- | ---- | --0 | ---- | --0 | ---- | --0 | --0 | --0 | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting